|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents (note 4) | ||||
| Short-term investments | ||||
| Trade and other receivables | ||||
| Research tax credit receivable | ||||
| Prepaid expenses and other assets | ||||
| Total current assets | ||||
| Non-current assets: | ||||
| Right-of-use asset | ||||
| Other assets | ||||
| Deferred tax asset | ||||
| In-process research and development asset | ||||
| Total non-current assets | ||||
| Total Assets | ||||
| Liabilities and Shareholders' Equity | ||||
| Current liabilities: | ||||
| Trade and other payables | ||||
| Current income tax liabilities | ||||
| Lease liability | ||||
| Total current liabilities | ||||
| Non-current liabilities: | ||||
| Lease liability | ||||
| Total non-current liabilities | ||||
| Total Liabilities | ||||
| Shareholders' equity: | ||||
| Share capital | ||||
| Other equity | ||||
| Deficit | ||||
| Accumulated other comprehensive income | ||||
| Total Shareholders' Equity | ||||
| Total Liabilities and Shareholders' Equity |
Loading...